4Kruijk JR, Leffers P, Menheere PP, et al. S-100β and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls[J]. Acta Neurol Scand, 2001,103 (3) :175 - 179.
5Kessler FH, Woody G, Portela LV, et al. Brain injury markers (S100β and NSE) in chronic cocaine dependents [J]. Rev Bras Psiquiatr, 2007,29(2) : 134 - 139.
6Basile AM,Fusi C, Conti AA, et al. S-100 protein and neuronspecific enolase as markers of subclinical cerebral damage after cardiac surgery:preliminary observation of a 6-month follow-up study [J]. Eur Neurol,2001,45(3) :151 - 159.
7Naeimi ZS,Weinhofer A, Sarahrudi K. Predictive value of S-100β protein and neuron specific-enolase as markers of traumatic brain damage in clinical use[J]. Brain Inj,2006,20 (5):463- 468.
8Bloomfield SM, McKinney J, Smith L, et al. Reliability of S-100β in predicting severity of central nervous system injury [ J ]. Neurocrit Care,2007,6(2) : 121 - 138.
9Loy DN, Sroufe AE, Pelt JL, et al. Serum biomarkers for experimental acute spinal cord injury:rapid elevation of neuron-specific enolase and S-100beta[J]. Neurosurgery. 200,56(2) :391 - 397.
10Herman M, Ebert AD, Galazky I, et al. Neurohavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue [ J ]. Stroke, 2000,31 (3) :645 - 650.
